Indy Gastro | Colonoscopy, rectal bleeding, diarrhea, constipation, endoscopy

Current Projects

About Our Studies

The Indianapolis Gastroenterology Research Foundation chooses to participate in studies which are highly likely to benefit patients of Indianapolis Gastroenterology and Hepatology. All IGRF studies have been approved by the Food and Drug Administration (FDA) and an independent review committee. Our patients participate at a stage when the drugs and regimens under study have been determined to be as safe as possible. Throughout a study, the FDA, an independent review committee, and the sponsoring pharmaceutical company carefully monitor the risk to patients. If risks increase over the course of a study, IGRF will discontinue participation in the study.

How to Join an IGRF Study

There are three ways to join a study conducted by Indianapolis Gastroenterology Research Foundation. In some cases, a patient’s doctor or nurse recommends him for a study. The IGRF Study Coordinator (SC) determines if the patient is a good fit and communicates a decision. In other cases, the SC contacts a patient directly because his condition presents a good match for an upcoming study. Finally, a patient may contact IGRF directly and ask to be included in a specific study or in any studies which fit his condition. Patients accepted for a study participate on a volunteer basis and may quit at any time. Please remember that consideration for inclusion in a study is no guarantee that you will participate in a study.

Our Study Coordinators

Each Study Coordinator (SC) is uniquely qualified to conduct medical trials. SCs have received training in nursing or other health professions. They are certified to conduct research on human subjects. The team of SCs at IGRF has over 35 years of combined medical experience.

During a study, the SC works closely with each patient’s physician. Patients may call their SCs with any study or health-related questions and concerns. The SC carefully monitors patient progress and gives each patient in the study a great deal of personal time and attention.

Research Projects Currently Enrolling Patients:

Crohn’s Disease

“We are currently collecting names of patients who are interested in being in a study for the treatment of active Crohn’s disease.  We have been contacted by several companies with possible projects scheduled to begin in early 2011.  If you are interested in talking to a study coordinator about this study, please email us at This email address is being protected from spambots. You need JavaScript enabled to view it. and leave your name, a contact number, and any other information that you think we would want to know.  We will contact you within 5 business days.”



 Hepatitis C

“We are currently collecting names of patients who are interested in participating in a study for the treatment of Hepatitis C.  We have been contacted by several companies with possible projects scheduled to begin in early 2011.  If you are interested in talking to a study coordinator about this opportunity, please email us at This email address is being protected from spambots. You need JavaScript enabled to view it. and leave your name, a contact number, and any other relevant information.  We will contact you within five business days.”

 


 IBS

“We are currently enrolling patients in a study to test a new treatment for patients who suffer from Irritable Bowel Disease with Diarrhea.  If you are interested in talking to a study coordinator about this opportunity, please email us at This email address is being protected from spambots. You need JavaScript enabled to view it. and leave your name, a contact number, and any other relevant information.  We will contact you within five business days."

 


 Barrett’s Esophagus

“We are currently participating in the HALO Registry.  This registry tracks the benefits of a procedure used for the treatment of Barrett’s Esophagus.  If you are interested in talking to a study coordinator about this opportunity, please email us at This email address is being protected from spambots. You need JavaScript enabled to view it. and leave your name, a contact number, and any other relevant information.  We will contact you within five business days.”

 


 Gastroparesis

“We are currently sponsoring an open access trial for the use of Motilium® (domperidone) in patients with gastroparesis.  This is a drug that has been used for several decades in Europe, Canada and Australia, but has not yet been approved by the FDA.  If you are interested in talking to a study coordinator about this opportunity, please email us at This email address is being protected from spambots. You need JavaScript enabled to view it. and leave your name, a contact number, and any other relevant information.  We will contact you within five business days.”

 

Corporate Sponsored Screening Colonoscopy Programs

“Indianapolis Gastroenterology Research Foundation has been a leader in the development and admistration of Corporate Sponsored Screening Colonoscopy Programs since 1995. Having a database of over 23,300 procedures involving almost 16,000 patients, and a network of providers in 15 states, we lead the industry in our ability to adequately screen large populations effectively.

If you would like more information on how IGRF can assist you in providing this much needed benefit to your employees, please contact Betsy Glowinski, RN, Executive Director at This email address is being protected from spambots. You need JavaScript enabled to view it. or (317) 865-2959. We are always interested in speaking on the value of a healthy work-force.”

Follow us on

Contact Indy Gastro

  • (317) 865-2955 & (800) 403-4683
  • Mailing Address

    8051 S. Emerson Ave.
    Suites 150 & 200
    Indianapolis, IN 46237

  • Contact UsView All Locatons